Urinary tract infection. Urinary tract infection, site not specified
Conditions
Interventions
Intervention 1: Intervention group: Oral vitamin A capsules (1,500 U/kg/day
a maximum of 50,000 U) were administered for 10 days (during the acute phase of infection). The vitamin A were provided by Jaber Ibn Hayyan pharmaceutical company,Tehran, Iran. Intervention 2: Contro
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: Positive urine culture for Escherichia coli Positive clinical manifestations of urinary tract infection Fever Renal scan indicating acute pyelonephritis
Exclusion criteria
Exclusion criteria: History of recurrent urinary tract infection Renal scarring on the baseline scan Frequent vomiting Severe dehydration Sepsis Systemic hypertension Neurogenic bladder Obstructive uropathy Low baseline serum levels of vitamin A Vesicoureteral Reflux grade >III Urinary calculi Voiding dysfunctions Any unilateral or bilateral renals anatomical anomaly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The condition of the clinical symptoms of urinary tract infection. Timepoint: One time before the treatment begins and daily up to 10 days after starting treatment. Method of measurement: clinical symptoms of urinary tract infection checklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| The persistence of the photopenic lesions with or without volume loss. Timepoint: At the beginning of the study (before the intervention) and 6 months later. Method of measurement: 99mTc-dimercaptosuccinic acid (DMSA) renal cortical scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactManijeh Kahbazi
Arak University of Medical Sciences
Outcome results
None listed